151 related articles for article (PubMed ID: 26854480)
1. [Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].
Vukoja V; Brandenbusch T; Tura A; Nassar K; Rohrbach DJ; Lüke M; Grisanti S; Lüke J
Klin Monbl Augenheilkd; 2016 Mar; 232(3):290-7. PubMed ID: 26854480
[TBL] [Abstract][Full Text] [Related]
2. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.
Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J
Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370
[TBL] [Abstract][Full Text] [Related]
3. [Overexpression of the receptor tyrosine kinase EphA2 in choroidal melanoma: correlation with vesculogenic mimicry and prognosis].
Chen LX; Sun BC; Li XR; He YJ; Song GX
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):985-90. PubMed ID: 23302271
[TBL] [Abstract][Full Text] [Related]
4. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.
Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A
BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356
[TBL] [Abstract][Full Text] [Related]
5. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
[TBL] [Abstract][Full Text] [Related]
7. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
8. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
Smith SL; Damato BE; Scholes AG; Nunn J; Field JK; Heighway J
Br J Cancer; 2002 Nov; 87(11):1308-13. PubMed ID: 12439722
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
11. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
13. Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis.
Stålhammar G; See TRO; Phillips SS; Grossniklaus HE
Mol Vis; 2019; 25():502-516. PubMed ID: 31588174
[TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
[TBL] [Abstract][Full Text] [Related]
15. EphA2 as a promoter of melanoma tumorigenicity.
Margaryan NV; Strizzi L; Abbott DE; Seftor EA; Rao MS; Hendrix MJ; Hess AR
Cancer Biol Ther; 2009 Feb; 8(3):279-88. PubMed ID: 19223760
[TBL] [Abstract][Full Text] [Related]
16. Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma.
Kim HS; Won YJ; Shim JH; Kim HJ; Kim J; Hong HN; Kim BS
Sci Rep; 2019 Mar; 9(1):3414. PubMed ID: 30833656
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 in uveal malignant melanoma.
Jay V; Yi Q; Hunter WS; Zielenska M
Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing fibrovascular septa from vasculogenic mimicry patterns.
Lin AY; Maniotis AJ; Valyi-Nagy K; Majumdar D; Setty S; Kadkol S; Leach L; Pe'er J; Folberg R
Arch Pathol Lab Med; 2005 Jul; 129(7):884-92. PubMed ID: 15974811
[TBL] [Abstract][Full Text] [Related]
19. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma.
Sabazade S; Gill V; Herrspiegel C; Stålhammar G
J Cancer Res Clin Oncol; 2022 Mar; 148(3):587-597. PubMed ID: 34775516
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
